Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves

Giuseppe Tarantini, Janarthanan Sathananthan, Tommaso Fabris, Uri Landes, Vinayak N. Bapat, Jaffar M. Khan, Luca Nai Fovino, Syed Zaid, Nicolas M. Van Mieghem, Azeem Latib, Ron Waksman, Ole De Backer, Toby Rogers, Lars Søndergaard, Gilbert H.L. Tang

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Given the longer life expectancy of these patients, the bioprosthetic valve will eventually fail, and aortic valve reintervention may be necessary. Although currently rare, redo-TAVR will likely increase in the future as younger patients are expected to outlive their transcatheter bioprosthesis. This review provides a contemporary overview of the indications, procedural planning, implantation technique, and outcomes of TAVR in failed transcatheter bioprosthetic aortic valves.

Original languageEnglish (US)
Pages (from-to)1777-1793
Number of pages17
JournalJACC: Cardiovascular Interventions
Issue number18
StatePublished - Sep 26 2022


  • redo-TAVR
  • transcatheter heart valve
  • valve in valve

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves'. Together they form a unique fingerprint.

Cite this